Why the study?
Does the ORBIT score improve prediction of major bleeding and death compared to the HAS-BLED score in anticoagulated atrial fibrillation patients?
Population
1,682 anticoagulated patients with atrial fibrillation from Spain, comprising 406 undergoing electrical…
Comparison
ORBIT bleeding risk score vs HAS-BLED bleeding risk score
Design
Cohort
Follow-up
Median 1,005 days for ECV cohort, 1 year for FANTASIIA…
Authors
Loading...
ORBIT does not outperform HAS-BLED for bleeding prediction in anticoagulated AF; leaves open whether refined scores can better guide decisions.
Does the ORBIT score improve prediction of major bleeding and death compared to the HAS-BLED score in anticoagulated atrial fibrillation patients?
The ORBIT score is not superior to the HAS-BLED score for predicting major bleeding and death in real-world anticoagulated atrial fibrillation patients, and HAS-BLED may better identify truly low-risk patients.
Esteve‐Pastor et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: